Moelis Healthcare/Life Sciences

Moelis has started recruiting summer analysts directly into Healthcare/Life Sciences in addition to the generalist M&A / RX program in NY. Anyone know how strong the group is/culture at the firm?

19 Comments
 

I can provide a bit of color. Worked with the various NYC healthcare MDs while I was an analyst there. All solid guys. Friendly, knowledgeable, generally good WLB. I can see they may want people who know more about healthcare technicals as I was mainly knowledgeable about M&A finance stuff given I hadn’t taken a healthcare/sciences course since high school. I think when I was there, all the analysts kinda felt like 1 MD in 1 Hc vertical was kinda tough to work for and we all felt like we had to take one for the team and everyone had to take a turn working on one of that MDs deals. I closed a nice deal with him and thought it was manageable but I can understand why others may not have actively sought to work for him. The good news is that it seems like the MD himself recognized that might not have been the best role for him and now is like the CSO at a major client. Looks like he has a great job and I’m happy for him. Overall, the rest of the team/MDs that I believe are still there are all solid, nice guys to work for in my opinion. Not sure if I have much more color to give you at this time as my info is a few years or so old 

 

Def can say that overall the deal flow is good; though a fair amount of it at the time was with the harder MD but I think Moelis still does well without him. I think Ken has been saying for a while now how excited he is about the HC space and how big the opportunity is for Moelis in that realm and how much he wants to invest in servicing the sector. 

 

did this happen again? the old life sci group head left a couple years ago to become a cfo but moelis represented them when his company got bought earlier this year

 

That’s one guy but op said the entire group is getting disbanded so are the other hc mds leaving too?

 

Itaque mollitia aliquam architecto ut aut. Voluptatibus nemo eaque optio commodi ut corrupti doloribus voluptatem. Ut hic numquam adipisci cupiditate impedit iusto.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”